Impact of Neuropsychological Evaluation on Epilepsy Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03202082|
Recruitment Status : Unknown
Verified June 2017 by University of South Florida.
Recruitment status was: Recruiting
First Posted : June 28, 2017
Last Update Posted : June 28, 2017
|Condition or disease||Intervention/treatment||Phase|
|Epilepsy||Behavioral: Neuropsychological testing||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Primary Purpose:||Health Services Research|
|Official Title:||Impact of Neuropsychological Evaluation on Epilepsy Treatment|
|Actual Study Start Date :||July 1, 2015|
|Estimated Primary Completion Date :||June 30, 2018|
|Estimated Study Completion Date :||June 30, 2018|
Experimental: Neuropsychological testing
Participants from this group will be administered a neuropsychological battery in addition to the initial and follow-up surveys
Behavioral: Neuropsychological testing
Neuropsychological testing evaluates various aspects of a participants cognitive ability as well as mood.
No Intervention: Treatment as usual
Participants from this group will be administered the initial and follow-up survey.
- Epilepsy Outcome Study Survey [ Time Frame: 2-4 months ]A brief questionnaire regarding the participants views on their epilepsy treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03202082
|United States, Florida|
|University of South Florida||Recruiting|
|Tampa, Florida, United States, 33612|
|Contact: Mike R Schoenberg, Ph.D 813-974-8900 email@example.com|